United Kingdom Male Aesthetics Market Size & Outlook, 2026-2034
United Kingdom Male Aesthetics Market Insights
- Deep Market Insights analysis indicates that the United Kingdom Male Aesthetics Market size, valued at USD 196.17 Million in 2025, is expected to expand to USD 367.45 Million by 2034.
- The United Kingdom market is forecasted to expand at a CAGR of 7.16% spanning 2026–2034.
- Injectable Procedures held the leading position among Treatment Modality segments in 2025, based on market size.
- Injectable Procedures is projected to post the fastest growth rate, sustaining its position as the most attractive Treatment Modality segment during the forecast horizon.
![United Kingdom Male Aesthetics Market Size, Share & Growth Analysis By [2034]](https://deepmarketinsights.com/uploads/charts/united-kingdom-male-aesthetics-market-united-kingdom-treatment-modality-254420.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, United Kingdom held 4.87% of the global Male Aesthetics Market size.
- By 2034, United States is anticipated to capture the largest share of the global Male Aesthetics Market.
- In Europe, Germany is expected to lead the regional Male Aesthetics Market size by 2034.
- France will remain the fastest-growing market in Europe, reaching USD 259.02 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 196.17 Million |
| Market Size In 2034 | USD 367.45 Million |
| Largest segment | Injectable Procedures |
| Units | Revenue in USD Million |
| CAGR | 7.16% (2026-2034) |
| Segmnetation Covered | |
| Treatment Modality |
|
| Target Indication |
|
| Service Facility |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Male Aesthetics Market Treatment Modality 2026-2034 (USD Million)
| Treatment Modality | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injectable Procedures | XX.x | XX.x | XX.x | 102.32 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Energy Based Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Surgical Enhancements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Male Aesthetics Market Target Indication 2026-2034 (USD Million)
| Target Indication | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Facial Aging | XX.x | XX.x | XX.x | 89.65 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Body Fat Reduction | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hair Loss Treatment | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Male Aesthetics Market Service Facility 2026-2034 (USD Million)
| Service Facility | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosmetic Clinics | XX.x | XX.x | XX.x | 91.67 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Multi Specialty Hospitals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Medical Aesthetic Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.